DC Circ. Says ViroPharma Can't Sue FDA Over Generics Ruling
The D.C. Circuit on Wednesday affirmed a lower court's decision that ViroPharma Inc. lacked standing to challenge a U.S. Food and Drug Administration ruling on generic drugs that allegedly set a...To view the full article, register now.
Already a subscriber? Click here to view full article